$SHOM NEW YORK, NY--(Marketwired - Jan 31, 2017) - Southern Home Medical Inc. ( OTC PINK : SHOM ), a leading developer of the healthcare industry, has announced that it will be expanding research and market onto Precision Medicine with cooperation and assistance from Dr. Zhongzheng Liu and President Obama's support via the "Precision Medicine Initiative". By promoting the use of personalized genetic information in the treatment of human diseases, breakthroughs in medical development can be achieved. SHOM will be diving headfirst into the market of Precision Medicine which is modeled to create $607 billion in health benefits.
Precision Medicine therapy is developed for the individual characteristics of each individual patient and is developed and designed based on the patient's susceptibility to specific diseases. The patient can be targeted for long-range treatment in the future, and individual characteristics can be identified at high risk. In addition, there is estimated to be a 10% reduction in instances of diabetes and cancer In the future, the YS government will invest 215 million US dollars to promote the program. SHOM will take the initiative forward and invest research into precision medicine in order to better its services and expand its market.
